Back to results
US 12,741,959 B2Granted
Belumosudil metabolites and uses thereof in the treatment of chronic graft-versus-host disease
AssigneeKadmon Corporation, LLC
InventorsOlivier Schueller, Jeegar P. Patel
Life of this patent
Estimating the term…
Abstract
The present disclosure provides metabolites of belumosudil and uses of the metabolites in of treating patients with ROCK2-mediated diseases including cGVHD.
Claims2
An isolated or synthesized monohydroxy belumosudil or belumosudil diol, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.